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A novel vanadate- and molybdate-sensitive human 
skin epidermal acid phosphatase was purified and char-
acterized. The enzyme was extracted from epidermal 
sheets with a 0.1 % Triton X -100 solution buffered at pH 
7.0. The purification procedure consisted of molecular 
permeation chromatography on Sephadex G-200 fol-
lowed b y chromatography on hydroxylapatite using an 
ammonium sulfate gradient. The molecular weight of 
the enzyme was 82,000 and the isoelectric point was at 
pH 5.6. At the optimum pH (5.1) the enzyme hydrolyzed 
most rapidly !-naphthyl phosphate (K,.. = 0.28 mM) and 
4 -nitrophenyl phosphate (K.., = 0.28 mM). In general, 
the best substrates had an aromatic leaving group. Flu-
oride (K1 = 39 J.LM; noncompetitive) and phosphate (com-
petitive) inhibited by binding to differe nt binding sites 
of the enzyme. The most potent inhibitors were vanadate 
(K1 = 1.9 x 10-6 M), tungstate (K1 = 1.4 x 10-7 M) , and 
molybdate (K1 = 2.0 x lo- !> M). Chemical modification 
and kinetic experiments suggested that the activity of 
the enzyme is based on imidazole, tyrosyl, and carboxyl 
groups. Benzoyl peroxide was a relatively potent inhib-
itor (K1 = 5.0 x 10-5 M; noncompetitive). This enzyme 
r esembled the prostatic acid phosphatase with regard to 
substrate specificity, inhibition characteristics, and 
functional groups. 
The epide rm al t issue of various mam malian species displays 
very high percentage contribu tion of acid phosphatase (AP) to 
the total hyd rolase activi ty and it has been concluded t hat t he 
phosphate esterases of epidermis serve some function unique 
to t his t issue [1 ,2 ]. ln ep idermis, AP activi ty is concentrated in 
those zo nes t hat undergo cell decomposition [3]. i.e., t he strata 
granulosum and corneum . Two distinctive AP-rich cellular 
systems, lysosoma l and cytoplasmic, have been demonstrated 
in human epidermis (4] . In skin , as in many other mammalian 
t issues, AP appears in multiple molecular forms. Such have 
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Abbreviations: 
AP: ac id phosphatase 
BPO: benzoyl perox ide 
DEP: diethylpyroca rbonate 
DSA: diazotized sulfanilic ac id 
EAP: epidermal acid phosphatase 
EEDQ: N -ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline 
El: enzyme inhibitor 
ES: enzyme substrate 
GPC: gel pe rmeation chromatography 
Mes: 2-(morpholino)ethanesulfonic acid 
NBS: N-bromosuccinimide 
PAP: prostatic ac id phosphatase 
TNM: tetranitrometbane 
v: rate (or velocity) of reaction 
V or V..,.,,: limiting rate (or maximum rate, or maxim um velocity) 
WRK: Woodward's reagent K (N-ethyl-5- isoxazolim-3' -sulfo-
nate) 
been demonstrated in cultured human skin fibroblasts (5], 
human psoriatic scales (6,7], rat skin [8- 10], and guinea-pig 
epidermis [11] . The glycoprotein nature of skin APs is consid-
ered to be related to t he generation of these mult iple forms, 
and to t he routing of these enzymes to lysosomes. 
Most studies on skin APs are mainly concerned with the 
localization and glycoprotein nature and the number of multiple 
molecular forms, usually revealed by isoelectric focusing. The 
chemical characterization of these enzymes has been empha-
sized only infrequently. This paper deals with a dominant form 
of the human epidermal APs, which was solubilized with 0.1 % 
Triton X-100. Emphasis was put on t he chemical modification 
of the enzyme and on the study of potent group-specific and 
other inhibitors, especially vanadate, tungstate, and molybdate, 
which have been shown to affect many phosphoryl t ransfer 
enzymes [12,13]. Fluoride and tar t rate were also used and the 
inhibit ion characteristics revealed are discussed in relation to 
t he localization of APs. 
A further aspect of AP chemistry which was discovered in 
t hi s study is the inactivation of the enzyme by benzoyl peroxide 
(BPO), an aromatic peroxide that has been used topically for 
burns, dermatites, wound healing, and for treatment of lesions 
caused by poison ivy and other irri tating agents [14]. BPO has 
been previously reported to inhibit the rabbit dental pulp Na-
K -ATPase [15]. My findings suggest t hat BPO inhibited the 
present human skin enzyme at concentrat ions that were much 
lower than t hose frequen t ly used in commercial BPO prepara-
t ions. According to t he literature available, this paper is the 
first that elucidates the chemica l nature of an AP from human 
skin . 
MATERIALS AND METHODS 
Separation of the Ep1:derm.is 
Abdominal human skin was obtained from autopsies of both female· 
and males who had met an accidental death. Epidermis was separated 
mechan ically from the dermis by stretching the defatted skin manually 
to its limit (1.5- 2 times its original length) and then removing the 
epidermis along its entire length by scraping with a scalpel [16]. 
Determination of Protein 
Protein concentrations were determined spectrophotometrically at 
220 nm [1 7] using bovine serum albumin as the standard. 
Epidermal Acid Phosphatase (EAP) Assay 
The determination of the EAP activity was performed at 30' C in 50 
mM Na-3,3-dimethylglutarate buffer, pH 5.0, using 1.0 mM 4-nitro-
phenyl phosphate as substrate, unl ess otherwise mentioned. The reac-
tions were stopped wi th 0.3 M NaOH. The amount of liberated 4-
nitrophenol was calculated using''""= 1.85 X 104 M- 1 cm-1.ln substrate 
specificity studies with other phosphates the amount of liberated phos-
phate was determined [18]. In enzyme modification studies the pseudo-
first order rate constant k.,. was calculated from the equation 
ln (E,/E2) = h.,,,(T2 - T ,) 
where E, and E2 are the observed ac tivi ties at t imes T, and T2 . 
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Molecu.lar Weight Determination 
The M, of' EAP was estimated by gel permeation chromatography 
(GPC) on a Sephadex G-200 column {1.5 X 140 em) in 10 mM Na-
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succinate buffer, pH 6.0. Bov ine -y-globulin (M, = 160,000), bovine 
serum albumin (67 ,000) , ova lbumin (45,000), chymotrypsinogen 
(25,000), and cytoc hrome c (12,400) were used as molecular markers. 
f soelectric Focu~ing 
Isoelectr ic focusing was performed at 4•c acco rding to t he instruc-
t ion manual of LKB-Produkter AB (Bromma, Sweden). T he ampholyte 
concentration was 1% with a pH range of 4- 6. An LKB 8100 column 
(1 10 ml) and Ampholine ampholytes at constant voltage (500 volts) 
were used. After focusing fo r 50 h the column was emptied at a constant 
rate of 15 ml/ h and 1.3 ml per tube was co llected. The pH value of 
every third fraction was determined with a combination electrode. 
Diazotization 
Diazotization of EAP with diazotized sulfani lic acid (DSA) was 
performed in 50 mM Na2CO" buffer, pH 8.0 [19]. Due to the labi lity of 
t he modifier, t he treatment was repeated at 10-min in te rvals with 5- 11l 
aliquots of freshly prepared aqueous DSA solutions (1.84 mg/ml = 50 
11M in the modificat ion mixture) to keep the concentration of DSA 
co nstant. DSA treatment did not change t he pH of the mixture. 
Modi fication te mperature was 25•c and the total modification time 
was 60 min. Su itable aliquots were withdrawn for t he EAP assay every 
10 min. T hese and other modification reactions indicated below were 
carried out under pseudo- first order condi t ions using the group reagent 
in excess. 
Nitration 
Nitration of EAP with tetran itromethane (TNM) was performed at 
25•c in 50 mM Tris- HCl buffer, pH 8.0, containing 0.1 mM EDTA 
[20]. The modification was started by adding 10 11l of ethanolic TNM 
to the modification mixture (fi nal concentrat ions 0 mM , 5 mM , and 10 
mM). T he modification time was 60 min and the rate of modification 
was monitored by remov ing small aliquots from the mixture for enzyme 
assay [18). 
Photochemical Oxidation 
Photochemical oxidation of EAP was performed with rose bengal as 
sensitizer. The reactions were carried out. at 25· c in 0.1 M Na-3,3-
dimethylgluta rate buffer, pH 5.7- 6.9, and in 0.1 M Tris-acetate buffer, 
pH 7- 9, with 10 11M rose benga l. Ca nalco Illuminator was used as a 
light source at a distance of 15 em. Cont rol modifications protected 
from light were included . The reactions were performed in glass tubes 
to cut out UV radiation. T he EAP act ivity was moni to red at 5-min 
intervals. 
Modification of Carboxyl Groups 
Chemica l modification of the enzyme with Woodwa rd 's reagent K 
(WRK) was carried out at 25•c in 50 mM 2- (mo rpholino)ethanesul fo nic 
acid (Mes)-NaOH buffer, pH 5.5, unless otherwise stated. Modification 
was stopped by diluting the enzyme into t he reaction mixture. Modifi -
cation of EAP with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline 
(EEDQ) was carried out as above, except that the buffer was 10 mM 
phosphate (p H 3.7- 7.5). In both modifica t ions the pH of t he medium 
was continuously adjusted to mainta in constant conditions. 
Co rbethoxylation 
Modification of EAP wit h diethylpyrocarbonate (DEP) was per-
formed at 25•c in 88 mM Na-aceta te buffer, pH 6.0 [19]. The reaction 
was initiated by adding l 11l of DEP into the modification mixture and 
a nother 2 11l at 30 min. Small aliquots were withdrawn at 10-min 
inte rvals to moni tor EAP activity. 
RESULTS 
This study deals wi t h t he purification a nd cha racterization 
o f an EAP which was extracted from human epiderm is with 
buffered 0.1 % Triton X-100. With t his t reatment one major 
AP was re leased from t he ep idermal material (Fig 1). The GPC 
was found sui table in t he pu rification of t he enzyme, but 
isoelectric focusing was excluded from t he final procedure be-
cause it was impossible to predict to what exten t t he ampholytes 
reacted with t he enzyme. This cautiousness was important in 
v iew of t he chemical modifications performed on t he enzyme. 
It was fou nd, instead, t hat chromatography on hydroxylapatite 
led to a n effective purification of the enzym e. T he isoelectric 
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F IG 1. Chromatography ofEAP. A , GPC of the supernatant solut ion 
of human epidermis on Sephadex G-200. Column- 1.5 em x 145 em; 
flow rate-3.9 ml h- 1 cm- 2; elu tion buffer-50 mM Tris-HCJ , pH 7.0, 
containing 0.1 mmol/ 1 EDTA; fraction volume-1.0 ml; sample vol-
urne-3.0 ml (extracted from 154.2 mg of epidermis) . B, lsoelectric 
focusing of the supernatan t fluid of human epidermal extract in a pH 
gradient of 4- 6. Fraction volume- 1.32 ml; sample- 2.0 ml (protein 
content 2.3 mg/ml). Other details are mentioned in t he Materials and 
Methods. 
foc usin cr showed, however , that t he epiderma l material con-
tained :small number of other APs with lower activity. 
Pllri{ication of EAP 
Epidermal sheets (882 mg) were suspend.e~ in 18 ml of cold 
10 mM phosphate buffer, pH 7.0, contammg 0.1 % Triton 
X-100 and 0.1 mM EDTA. The mixture was left overnight at 
4 ·c after which it was centrifuged for 30 min at 78,000 g and 
at 4 ·c. The clear supernatant was ultrafiltrated (cut -off 10,000 
daltons) under nitrogen at 3 kg/cm2 to reduce the volume. The 
concentrate was chromatographed on a Sephadex G -200 col-
umn (3.4 x 140 em) which was equilibrated with 10 mM Na-
succinate buffer, pH 6.0, con taining 0.1 mM EDTA. The frac -
tions containing EAP were pooled. The pool was applied on a 
hydroxylapatite column (1.8 X 43 em) which was equilibrated 
with 10 mM Na-succinate buffer, pH 6.0. T he EAP was eluted 
with a linear ammonium sulfate gradien t (0- 1 M in the above 
buffer; mixing volume 150 ml + 150 ml; flow rate 0.8 ml h- 1 
cm- 2). In a typical run 53 ml of enzyme (0.065 mg protein per 
ml) was applied on the column. The enzyme was detached at 
0.5 M ammonium sulfate . The active fract ions were poo led and 
concentrated by ult rafi ltration to 3 ml. The purified EAP was 
dialyzed at 4 oc for 24 h against a proper buffer (1000-fold 
volume) , which was chosen on the basis of t he subsequent 
modification studies carried out. With this procedure -99% of 
fore ign p rote ins were removed (Table I). In spite of effective 
removal of impurities, t he enzyme yield was low due to destruc-
t ion of enzyme activ ity during purification. T he EAP was 
considered, however, homoge nous as far as enzyme activity was 
concerned (on ly one molecular fo rm was present) , a nd pure 
enough for t he modification studies that were based on activity 
measurements. Consequently, further purification was consid-
=--" 
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TA BLE ]. Purifica.t.ion. of human. epidermal A P 
Specific activity Recovery of 
Step Total protein (nmol min- 1 ori ginal content (m g) mg- ' ) enzyme activity 
Extraction of epidermis 35.9 44.2 100 
with buffered Triton" 
Gel permeation chroma- 3.71 211.2 49.3 
tography on Sephadex 
G-200 
Chromatography on 0 .. 56 562.0 18.8 
hydroxylapatite 
"The ori ginal material consisted of 882 mg of epidermal sheets that 
were treated with a mild Triton X-100 solu tion to yield an enzyme 
preparation wh ich contained a relatively small amount of protein . 
Increase of Triton conce ntration would have increased purification 
factor but rendered purification more dir!icult. 
TABLE II. Relative rate of the hydrolysis of phosphate esters by EAP 
in .50 mM Na-3,3-dimethylglut.arate buffer, pH 5.0 at 3o•ca 
Substrate (0.5 mM) Relative hydrolysis K., (mM) 
4-Nitrophenyl phosphate 100 0.28 
1-Naphthyl phosphate 131 0.28 
Phenyl phosphate 79 0.70 
Pyridoxal 5' -phosphate 81 2.20 
Ribol1avin 5' -phosphate 17 0.70 
Adenosine 5' -monophosphate 21 
Adenosine 5' -diphosphate 2 
Adenosine 5' -triphosphate 0 
Sodium pyrophosphate 0 
"The rate of the hydrolys is of 4-nitrophenyl phosphate is marked as 
l 00 and the others are given as relative values. 
ered unnecessary a nd a lso unfeasible in view of the nature of 
t he starti ng mate ria l. 
Molecular Weight and Isoelectric Point 
An M , of 82,000 and a n isoelectric point of 5.6 (Fig lB) were 
obtained for the EAP. Traces of high - and low-M, APs were 
shown by t he chromatograms, but t hese enzymes were excluded 
from t his study due to t heir low activity. Increase of t he 
detergent concentration would most like ly have increased t he 
relative amount of the high-M, APs eluted in t he void volume 
(Fig lA) . 
S ubstrate Specif,:city 
EAP hydrolyzed most rapidly !-napht hyl phosphate of a ll 
those substrates tested. All acceptable substrates had an a ro-
matic leav ing group (a group which is only weakly bound to a 
subs ite of t he binding site, and which is di splaced by EAP from 
t he substrate ). The relative hydrolysis rates for different phos-
phate compounds are listed in Table II. The K, values for the 
best substrates, determined using t he doubl e reciprocal plot 
[21], a re a lso given . EAP had no ATPase or pyrophosphatase 
activi ty. Of the adenosine phosphates, only AMP was hydro-
lyzed at a significant rate. 
Fluoride Inhibition. 
Fluoride was a fairly potent, noncompetitive inhibitor of 
EAP. A drop of inhibi t ion took place, however, at hi gh [fluo-
ride], t he inhibi t ion being a function of t he square of the 
[fluoride] (Fig 2). A K; value of 39 J.LM was estimated graphically. 
The binding of flu oride to EAP was studied also with a multiple 
inhibi tion ana lysis using the Yonetani -Theorell plot [22,23]. In 
this case flu oride (a noncompetit ive inhibitor) in t he presence 
of phosphate (a linear competitive inhibi tor) yielded parallel 
Dixon plots (reciprocal velocity vs inhibi tor concent ration) , 
suggesti ng that t hese inhibitors were mutually exclusive, al-
t hough t hey must have bound to di ffe rent sites of t he enzyme 
0 0.05 
[1] mM 
Vol. 85, No.2 
0.1 
FIG 2. Inhibi tion ofEAP by fluoride in 50 mM Na-3,3-dimethylglu-
tarate buffer, pH 5.0. A, Plot of 1/ v vs [1] 2 , where vis the initial velocity 
and [I] the inhibitor concent ration. The arrow shows the intersection 
point, -(KY, of the straight lines with the x-axis. 8, Plot of 1/v vs 
[1) . Substrate concentrations: S1 = 0.05 mM; S2 = 0.25 mM; S3 = 0.50 
mM; S4 = 1.00 mM. 
TABLE Ill. Valu es of the inhibition constant , /(;, in /.he competitive 
inhibit ion of EAP" 
Inh ibit or 
Phosphate (H2PO,- ) 
L(+)-Tart.rate 
o(- )-Ta rtrate 
Vanadate (VQ"- ) 
Tungstate (WO/- ) 
Molybdate (Moo/-) 
I<; (M) 
1.0 x w-" 
6.0 X 10-5 
No inhi bition 
1.9 X 10- 6 
1.4 X 10-7 
2.0 x w-9 
"The reactions were performed in 50 mM Na-3,3-dimethylglu tarate 
bu fTer, pH !i .O. The va lues of K; were obtained from plots of 1/ v vs [1) . 
[23]. Fluoride did not hinder the formation of the enzyme 
substrate (ES) complex; the latter was not dissociated, however. 
It is possible that fluoride sterically hindered phosphate bind-
ing, and a lso substrate binding, or it may have distorted the 
enzyme molecule sufficient ly to prevent the proper posit ioning 
of t he catalytic center. 
Other Inhibitors 
Table III lists several competitive inhibitors of the enzyme. 
The most potent inhibitor was molybdate. Vanadate and mo-
lybdate ar e known to act as structural and electronic analogues 
of t he t ransition state for phosphate hydrolysis [13]. This 
suggestion was verified in this study using the multiple inhibi-
tion analysis of t he enzyme by molybdate in the presence of 
phosphate, both being competitive inhibitors. The parallel lines 
in the Yonetani-Theorell plot (Fig 3) indicated that these 
inhibitors were mutua lly exclusive and cannot simultaneously 
bind to the enzyme. Therefore, molybdate acted as a phosphate 
ana logue in binding to the active site on the enzyme which 
normally ligands t he phosphate anion. It is to be expected that 
tartrate, t ungstate, and vanadate ions would behave in an 
identical way in the presence of phosphate. 
Effect of pH on. EAP Activity 
The effect of pH was studied in 50 mM Na-3,3-dimethylglu-
tarate buffers, pH 3.5-6.9. The optimal pH of EAP was 5.1 at 
[substrate] ([SJ) = 20 x Km. At low [S] a broad plateau of 
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F IG 3. T he Yonetani-Theorell plots of 1/v vs inhibitor co ncentra-
t ion in t he inhibition of EAP by molybdate a nd p hosphate at fix ed [SJ 
(1 mM). A, Inhibi t ion by phosphate in the presence of molybdate at 3 
different concentratio ns: 0, 0. 1 x 10- 7 M, and 0.5 X 10-7M. B, Inhibit ion 
by molybdate in the presence of phosphate at 3 different concent ra-
tion s: 0, l.O mM , and 5.0 mM . All reactions were performed in 50 mM 
Na-3,3 -dimethylglu t.arate buffer, pH 5.0. T he phosphate used was 
Na2 HPO, and t he molybdate was (N H.,)nMo70 ",·4 H20 . 
optimal activity was observed on the ac id side of pH 5.0. The 
pK, vs pH graphs showed an upward bend with inf1ection at 
pH 4.5. This int1ection corresponded to t he pK of a group in 
t he ES complex and it co incided with the downward bend 
observed in the logY vs pH graphs. The pK,. vs pH graphs also 
showed an inflection at about pH 5.3, which probably repre-
sented the ionization of the substrate ( 4- nit rophenyl phos-
phate). The inf1ection at pH 5.9 (pKo2 ) observed in the logY vs 
pH graphs should represent a group of the free enzyme, i.e., a 
group which is involved in t he catalysis only. Plotting of log(Y / 
K m) vs pH should leave only the constant of free enzyme and 
free substrate cancelling the inf1ections due to pKs of groups 
in t he ES-complex [24]. This plot revealed an inf1ection at pH 
5.3, represent ing the pK of the free substrate. These pH effects 
support t he involvement of a group with a pK value of 5.9 
(possibly histidyl residue or a carboxyl group) in the function 
ofEAP. At first sight t his value would be too high for a carboxyl 
group. However, chemica l modification of EAP showed that 
th is enzyme contains an active carboxyl group which displayed 
an unusually high pK value (see below) . Consequently, t he 
group with a pK value of 5.9 could also be a carboxyl group. 
P hotoinactiuation 
The photochemical inactivation of EAP in t he presence of 
rose bengal in buffered solut ions from pH 5.7 to 9.0 showed a 
pH dependence of oxidation similar to that of histidine [25]. 
Effect of Carboxyl Group R eagents 
F ig 4 shows that the inactivation of EAP by EEDQ was both 
time- and concentration-dependent. The pH of the modifica-
tion medium had a remarkable effect of t he inactivation rate. 
When the inactivat ion was studied between pH values 3.7- 7.5, 
a sigmoida l curve of inactivation was observed, t he process 
being more pronounced at acid pH (pK 5.9). Protonated car-
boxyl group is necessary for EEDQ reactivity [26]. The inacti-
vation of EAP was also achieved with another highly spec ific 
carboxyl group reagent: WRK (Fig 4B). This inactivation fol-
lowed pseudo-first order kinetics for some time, after which the 
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FIG 4. Involvement of carboxyl group(s) in EAP activity. A , Effect 
of pH on the inactivation of EAP by 20 mM EEDQ in 10 mM phosphate 
buffer and by 15 rnM WRK in 50 mM Mes-NaOH buffer at 25·c. The 
arrow indicates the inflection point of 5.9. B, Inactivation of EAP by 
20 mM EEDQ in 10 mM phosphate buffer, pH 5.5, and by 15 mM WRK 
in 50 mM Mes-NaOH buffer, pH 5.5. knp1> is t he apparent rate constant 
of inactivat ion. 
disappearance of the reagent by hydrolysis became noticeab le. 
The activity of EAP was rapidly decreased by WRK in Mes-
NaOH buffer at pH 5.5. The rate of inactivation was higher at 
pH 6.0, but the stabili ty of the reagent was poor at higher pH 
values. 
Nitration and Dia.zotization 
The inactivation of EAP by TNM was time- and concentra -
tion-dependent (Fig 5). T he kinetic data were subsequently 
plotted according to Levy et a l [27] for _ t he calculation of t he 
order of reaction with respect to mhJb1tor (not shown) . The 
plot of Jog 1/to.s against log[TN~] ~a_v~ a straight line wit~ a 
slope of 1.03, indicating that the mhJbJtJOn was first order w1th 
respect to [TNM] . A further plot of to.5 against the reciprocal 
of [TNM] also gave a straight line starting from the origin , 
indicating that no formation of a reversible enzyme inhibitor 
(El)-complex prior to the inactivation step had occurrred (Fig 
5A inset) [28]. Treatment of EAP with DSA at pH 8.0 resul ted 
in ~ complete Joss of enzyme activity in 60- 70 min (Fig 5B) . 
The pattern of inactivation by both modifiers was similar; no 
residual EAP activity, for example, was found after the treat-
ments. 
Ca.rbethoxy la.tion 
Treatment of EAP with DEP was carried out at pH 6.0, a 
condition which favors carbethoxylation of his tidy! residues as 
compared to other residues. Fig 6 shows t hat the addition of 
5.6 J.LIDOl of DEP (final concentration 11.2 mM) inactivated the 
enzyme to a certain extent. A further addition of 5.6 J.Lm ol DEP 
(fi nal level 22 mM) resulted in a strong inactivation of EAP in 
60 min. Complete inactivation was achieved after longer t reat-
ment. A buffer that is most often used in modification experi -
ments with DEP is potassium phosphate. However, because 
phosphate ion protected EAP against inactivation by DEP, 
acetate buffer was used instead. The finding that inactivation 
of EAP by DEP was prevented by phosphate speaks for the 
involvement of a histidyl residue at t he substrate binding site. 
Other Modifications 
N -Bromosuccinimide (NBS), which has been used in t ryp -
tophan modificat ion, potently inactivated the EAP: 77 J.LM NBS 
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F'lG 5. In volvement of ty rosyl group(s ) in the activity of EAP. A , 
Inactivation of EAP by TNM in 50 mM Tris- HCI buffer (the pH was 
adjusted to 8.0 a·nci maintained at this va lue). Inset, Plot of 41.,, vs 1/ 
[TNM], where to.5 is the time for 50% inactivation. The values of 
apparent inactivation consta nts, k.,,, are indicated. B, Inactivation of 
EAP by DSA at pH 8.0 [19]. 
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F'fG 6. Modification of EAP by DEP. The reactions were performed 
in 88 mM acetate buffer, pH 6.0. Two co nsecutive additions of DEP 
were made (arrow.~). 
inactivated by 77% in 60 min and 0.154 mM NBS inactivated 
by 86% in 10 min. The inactivation was biphasic: the initial 
reaction was too rapid (lasting less than 30 s) to be accurately 
measured. The above inactivation percentages were obtained 
from the slower inactivation phase. Na-p-chloromercuriben-
zoate competitively inhibited the EAP (/{, = 0.02 mM) . 
Inhibition by BPO 
The inhibition of EAP by BPO was studied in 50 mM Na-
3,3-dimethylglutarate buffer, pH 5.0, using the plots of 1/v vs 
[I] and [S] /v vs [I] as suggested by Cornish-Bowden [29]. The 
inhibition type was noncompetitive. The Dixon plot of 1/v vs 
[I] gave a value of 4 X 10-" M forK (mean of 3 determinations). 
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FIG 7. Inhibition ofEAP by BPO in 50 mM Na-3,3dimethylglutarate 
buffer, pH 5.0. A, Plot of maximum velocity against the total enzyme 
concentration E, for the uninhibited (control) reaction and for the 
inhibited reaction at [BPO] = 0.12 mM. BPO was dissolved in aceto-
ni t rile. The corresponding amount of acetonitrile was added to the 
control mixtures without BPO. The intersection of the latte r curve 
with x-axis indicates the amount of EAP that was irreversibly inacti-
vated. 8, Inhibition of EAP by BPO, benzoic acid (both dissolved in 
acetonitrile) and H20 2 • The BPO experiments were carried out using a 
30-min reaction time (without preincubation) under normal laboratory 
illumination. 
A substance which irreversibly inactivates an enzyme is 
sometimes (incorrectly) called a noncompetitive inhibitor be-
cause V "'"' is decreased. Irreversible inhibition and reversible 
noncompetitive inhibition may be distinguished by plotting 
Ymnx vs [E,], where [E,] represents total units of enzyme activity 
added to the assay [30]. For a reversible noncompetitive inhib-
itor, the "plus inhibitor" curve will have a smaller slope than 
the control curve and will go through the origin. If an irrever-
sible inhibitor is present, the "plus inhibitor" curve will have 
the same slope as the control curve (Fig 7), but will intersect 
the horizontal axis at a position equivalent to the amount of 
enzyme [E;,] that is irreversibly inactivated. With EAP, the 
V "'"' vs [E,] plot suggested partly irreversible inhibition by 
BPO. This is shown in Fig 7A which also gives the enzyme 
fraction that was dest royed in the presence of 0.12 mM BPO. 
Multiple inhibition studies of the system EAP-BPO in the 
presence of phosphate (competitive inhibitor) showed that 
these two inhibitors were not mutually exclusive and that they 
must bind to different sites of the enzyme (not shown). It is 
possible that the phosphate is bound to the active site through 
an imidazole group [13]. Kono et al [15] showed that the BPO-
inactivated Na-K-ATPase of dental pulp was reactivated by 
SH-compounds. One millimolar cysteine or 1 mM imidazole did 
not protect or reactivate EAP, however. This suggests that 
BPO did not primarily react to the active site of EAP. In vitro 
studies using excised human skin have shown that BPO is 
almost completely metabolized to benzoic acid during its pen-
etration through the skin [14]. Fig 7B shows that benzoic acid 
and H20 2 were less inhibitory by far than BPO. 
DISCUSSION 
No effort was made to localize the EAP in this study; the 
purpose was to characterize the dominant EAP that was so]u-
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bilizable with 0. 1% detergent. It has been suggested, however, 
t hat the AP from epidermis is t he same enzyme in different 
intracellular localizations [ 4] and other studies indicate that 
the active site structures of APs have a common ancestral 
origin (31-33]. Tartrate has been used to demonstrate t he 
lysosomal localization of APs [34]. The prostatic acid phospha-
tase (PAP) which is very sensit ive to tartrate is not, however, 
confined to lysosomes. Accordingly, in human epidermis t he 
inhibi tory effect of tartrate is not restricted to t he lysosomal 
AP only, but to the cytoplasmic enzymes as well [4) . The 
present EAP was sensitive to L-tartrate, o -tartrate being with -
out effect. Consequently, the present tartrate data cannot be 
used to firmly establish t he locali zation of the human EAP. 
S ubstrate Specificity 
The substrate specificity of EAP resembled that of the prin-
c ipal prostatic isoenzyme [35], t he preferred synthet ic sub-
strates being aryl phosphates with 4-nitrophenol, 1-naphthol, 
or phenol as the leaving group. AP from either source did not 
catalyze the hydrolysis of pyrophosphate or ATP. The leaving 
group seems not to be very critical, as far as it is a ring structure, 
because a compound as bulky as ribofl avin 5' -phosphate was 
accepted. Pyridoxal 5' -phosphate was another good substrate. 
In rat skin on ly 1 of the 4 APs discovered was capable of 
hydrolyzing th is substrate (8]; it was not hydrolyzed by micro-
somal and soluble APs either (36] . The preserving of t he 
constancy of the cellular content of pyridoxal phosphate has 
been suggested to be one of the in vivo functions of acid and 
a lkaline phosphatases [37]. The 4-nitrophenyl phosphatases of 
animal t issues may also act on phosphotyrosyl-proteins (but 
not phosphoseryl-proteins) , regardless of whether these en-
zymes exhibit an optimum at either acidic or alkaline conditions 
[38]. 
Sensitiv ity to Vanadate, Tungstate, and Molybdate Ions 
A common feature for the APs from human prostate, liver, 
and epidermis is the sensitivity of these enzymes to tartrate, 
vanadate, and molybdate. Of special interest is the finding that 
skin differs substantially in its behavior toward molybdate in 
comparison with other tissues investigated [39]. Only skin 
shows strong capability of molybdate retention, and skin is the 
site of highest tissue concentration of molybdate (40]. The 
concentration of vanadium in mammalian tissues is 10- 7 to 
10-6 M. Since the K values of t he EAP for va nadate, tungstate, 
and molybdate ions were equal or less than 1 1-!M , it appears 
that the phosphohydrolytic activity of EAP in vivo could be 
influenced by these ions. This t ight binding of vanadate, tungs-
tate, and molybdate to EAP suggests that these ions could act 
as structural and electronic analogues of the transition state 
for phosphate hydrolysis [ 13]. This structural analogue theory 
was supported by the results of Fig 3. Those enzymes currently 
known [12] to be either inhibited or inactivated by vanadate, 
for example, are almost all phosphohydrolases and their mech-
anism of action includes a covalent phosphoenzyme interme-
diate . 
Sensitivity to Fluoride 
Fluoride is another common inhibitor of phosphoryl transfer 
enzymes. In t1uoride inhibitions a biphasic effect seems to be a 
common feature. At low [F] and at acid pH a small part of t he 
fluoride in solution exists as a dimer HF2- which may compete 
with the substrate (42]. At high [F] a higher polymer, 
(HF2)~-, may participate. If this polymer were assumed to be 
displaceable by the substrate, the drop in inhibition by high 
[F] (Fig 2) cou ld be explained. EAP showed noncompetitive 
inhibition by fluoride and the inhibition was a function of the 
square of [F], resembling in th is sense the PAP [42]. The 
multiple inhibition analysis of EAP gave evidence that f1uoride 
and phosphate ions were mutually exclusive (Fig 2); t he halide 
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was bound directly to the enzyme molecule, not to the active 
site . The EAP and the PAP [42] were also in this sense similar 
enzymes. 
Functional Groups 
The APs involve phosphoenzyme intermediates, and imida-
zoly l, hydroxyl, and carboxylate groups are preferred acceptors 
for phosphoryl group transfer. Thiol , tyrosyl, and lysyl groups 
may also react [43]. No evidence for essent ia l lysyl residues has 
been obtained with PAP, however [44]. In human PAP the 
tyrosyl residues probably are not directly involved in the cata-
lytic function; they may rather stabilize t he active enzyme 
conformation [45]. In some other enzymes catalyzing phos-
phoryl transfers an active tyrosine has been shown to exist [ 46-
48]. The high TNM concentrations needed for the inactivation 
of EAP also speak in favor of a stabilizing role of tyrosine. 
Kinetic evidence showed that only one tyrosine in the EAP 
was attacked by TNM. Because TNM does not react with 
histidine or acetylhistidine and possesses a good degree of 
specificity for the tyrosyl residue, it can be concluded that a 
tyrosyl residue is necessary for the activity ofEAP. Two orders 
of magnitude lower concentration of DSA was sufficient to 
inactivate EAP. DSA modifies tyrosine in preference to histi-
dine (49). 
The presence of an active histidine was supported by the 
findinas that DEP destroyed more than 80% of EAP activity 
at pH G.O. Further evidence was obtained from photooxidation 
studies. In the pH range tested, the inactivation followed 
pseudo-first order kinetics, suggesting that destruction of a 
single amino acid residue in the EAP caused a complete loss of 
enzyme activity. The pH profile of inactivation closely resem-
bled that of imidazole. Furthermore, the pH dependence curves 
of the destruction by photooxidation of other amino acids like 
methionine, tyrosine, and tryptophan do not show pH depend-
ence at pH values between 5 and 9 (25] Finally, the logV vs pH 
graphs revealed a group of pK = 5.9 which is suitable for 
imidazole, although the possibility that it belongs to glutamic 
or aspartic ac id cannot be excluded. The human PAP has also 
been characterized as a histidine phosphatase [50]. Strong 
ev idence of the involvement of phosphohistidine as an inter-
mediate also in reaction cata lyzed by an AP from wheat germ 
(51,52] and rat liver [53] has been presented. 
Other chemical groups participating in the hydrolysis of 
phosphomonoesters by APs include arginine [54], cysteine 
[55], and the carboxyl group [56]. The role of aspartic or 
glutamic acid would be to provide a general acid catalyst to 
protonate the leaving R-0- group for the reaction to proceed 
rapidly (50]. Human PAP was inactivated by WRK in condi-
tions where the inactivation could be concluded to result from 
the inactivation of an active site residue (one per active site) 
[57]. The present EAP was also inactivated almost completely 
with this reagent which is rather specific for carboxyl groups. 
Complete inactivation was also obtained with EEDQ, another 
specific carboxyl group reagent. The pK value of 5.9 observed 
in the logV vs pH graphs could also represent a carboxyl group 
instead of an imidazole, because t his same pK value was ob-
ta ined when studying the pH dependence of the inactivation of 
EAP by EEDQ (Fig 48). Unusually high pK values, even as 
high as 7.1, have been suggested to be present in ATPases 
[26]. 
The inhibit ion of EAP by BPO was a specific effect of the 
aromatic peroxide itself. This is an important observation, since 
the efticacy of several peroxidatic compounds (such as boric 
acid) is based on the formation of H20 2. In my experiments, 
H20 2 was by far less effective than BPO. The final inhibitory 
species may be a benzoyl radical. 
In summary, this paper described the purification and char-
acterization of a novel EAP from human skin, that resembles 
the PAP with regard to substrate specificity, inhibition char-
acteristics, and functional groups. 
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